Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (PNK:SFOSF).
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerSFOSF Technical Analysis Summary
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. stock currently trades in a neutral range, with no clear dominance from buyers or sellers.
Technical conditions suggest Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is consolidating, awaiting a decisive move.
RSI (14): 35.71
Stochastic %K: 43.42
Williams %R: -41.18
Rate of Change (ROC): -6.90
Takeaway:Shanghai Fosun Pharmaceutical (Group) Co., Ltd. shows neutral momentum, with indicators pointing to indecision.
MACD: -0.07
ADX: 14.10
ATR (14): 0.03
CCI (14): 64.43
Takeaway:Shanghai Fosun Pharmaceutical (Group) Co., Ltd. shows a neutral trend, with weak conviction and limited volatility.
Takeaway:Shanghai Fosun Pharmaceutical (Group) Co., Ltd. trades near the upper band, signaling overbought conditions and risk of pullback.
Takeaway:Shanghai Fosun Pharmaceutical (Group) Co., Ltd. trades near the upper channel, signaling resistance and risk of pullback.
Overall Takeaway:SFOSF shows mixed signals in money flow analysis.
Bullish Signals
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
Price near upper Bollinger Band → potential resistance and pullback risk.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Technical indicators for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. are mixed, suggesting a Hold or wait-and-see approach.